Prestige BioPharma Limited (KRX:950210)
5,860.00
+40.00 (0.69%)
At close: Sep 22, 2026
| Market Cap | 70.43B -60.1% |
| Revenue (ttm) | 16.21B +87.1% |
| Net Income | -57.32B |
| EPS | -953.45 |
| Shares Out | 12.02M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 25,203 |
| Open | 5,830.00 |
| Previous Close | 5,820.00 |
| Day's Range | 5,750.00 - 6,000.00 |
| 52-Week Range | 4,945.00 - 15,110.00 |
| Beta | 0.36 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 23, 2026 |